Serum biomarkers associated with SARS-CoV-2 severity

Immunity with SARS-CoV-2 infection during the acute phase is not sufficiently well understood to differentiate mild from severe cases and identify prognostic markers. We evaluated the immune response profile using a total of 71 biomarkers in sera from patients with SARS-CoV-2 infection, confirmed by...

Descripción completa

Detalles Bibliográficos
Autores principales: de Morais Batista, Fabiani, Puga, Marco Antonio Moreira, da Silva, Patricia Vieira, Oliveira, Roberto, dos Santos, Paulo Cesar Pereira, da Silva, Bruna Oliveira, Tatara, Mariana Bento, Tsuha, Daniel Henrique, dos Santos Pires, Maria Aparecida, Gonçalves, Crhistinne Cavalheiro Maymone, Pessoa e Silva, Rômulo, Ferreira, Nathália Tavares, de Barros Albuquerque, Amanda Pinheiro, da Silva Duarte, Giselle, Consolaro, Márcia Edilaine Lopes, Negrão, Fabio Juliano, Ferrari, Idalina Cristina, de Goes Cavalcanti, Luciano Pamplona, Trinta, Karen Soares, Ribeiro, Guilherme S., de Melo Rêgo, Moacyr Jesus Barreto, Boyton, Rosemary J., Siqueira, André Machado, Altmann, Daniel M., Croda, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511452/
https://www.ncbi.nlm.nih.gov/pubmed/36163447
http://dx.doi.org/10.1038/s41598-022-20062-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511452/
https://www.ncbi.nlm.nih.gov/pubmed/36163447
http://dx.doi.org/10.1038/s41598-022-20062-5

Ejemplares similares